ERBB2 and breast cancer: In HER2-positive breast cancer, loss of HER2 positivity after NAC has been reported to be 8–32% [15, 17–19], and in HER2-negative breast cancer, gain of HER2 positivity after NAC has been reported in 0–5% of cases [15, 17].